Adamas Announces New Employment Inducement Grants

Rhea-AI Summary

Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) announced the granting of restricted stock units for 94,750 shares to seven new employees. These units will vest over three years and are part of the 2016 Inducement Plan approved by the board in March 2016. This initiative aims to attract new talent to enhance the company's focus on developing innovative therapies for neurological diseases, ultimately addressing the challenges faced by patients and caregivers.

Positive

• Granting of restricted stock units may improve employee retention and satisfaction.
• Initiative supports the company's strategy to attract new talent.

Negative

• None.

EMERYVILLE, Calif.--(BUSINESS WIRE)-- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted seven new employees restricted stock units to acquire 94,750 shares of the company’s common stock. The restricted stock units vest over three years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the company's board of directors in March 2016 under Rule 5653(c)(4) of the Nasdaq Global Market for equity grants to induce new employees to enter into employment with the company.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210910005553/en/

Media:

Sarah Mathieson

Vice President, Corporate Communications

510-450-3528

smathieson@adamaspharma.com

Investors:

Peter Vozzo

Westwicke Partners

443-213-0505

peter.vozzo@westwicke.com

Source: Adamas Pharmaceuticals, Inc.

FAQ

What did Adamas Pharmaceuticals announce regarding employee compensation on October 2023?

Adamas Pharmaceuticals announced granting restricted stock units for 94,750 shares to seven new employees.

How long do the restricted stock units vest for Adamas Pharmaceuticals employees?

The restricted stock units will vest over a period of three years.

What plan is associated with the stock units granted by Adamas Pharmaceuticals?

The stock units are part of the 2016 Inducement Plan approved by the board.

Why did Adamas Pharmaceuticals grant restricted stock units?

The stock units were granted to induce new employees to join the company.